Cheng Jie, Liu Ya, Li Shaojun, Pu Kaibin, Yang Lin, Tan Liping
Department of Emergency, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Children's Hospital of Chongqing Medical University, Chongqing, 400014, People's Republic of China.
Department of Pediatrics, Chongqing Youyoubaobei Women and Children's Hospital, Chongqing, 401147, People's Republic of China.
Infect Drug Resist. 2024 Feb 9;17:543-550. doi: 10.2147/IDR.S449731. eCollection 2024.
Third-generation cephalosporin-resistant (3GC-R) bloodstream infection (BSI) is associated with poor prognosis. We investigated the incidence of and risk factors for 3GC-R () BSI in children.
Patients with BSIs who were hospitalized at the Children's Hospital of Chongqing Medical University were retrospectively enrolled. Univariate and multivariate logistic regression analyses were used to identify the independent risk factors for 3GC-R BSI.
Two hundred fifty-two children with BSIs were enrolled. The mortality rate was 11.51% (29/252). The infection rate of 3GC-R was 48.81% (123/252), and the incidence of BSI during hospitalization was 18.58 per 1000 person-days. Approximately half (47.22%, 119/252) of the children were infected with extended-spectrum beta-lactamases (ESBLs) produced by . More than one-third (37.30%, 94/252) of the children were unnecessarily administrated carbapenems. According to our logistic regression analysis, a history of carbapenem administration, an elevated Pediatric Sequential Organ Failure Assessment (pSOFA) score ≥2, and antimicrobial agent administration before blood culture were independently associated with 3GC-R BSI (odds ratio [OR] 2.05, 95% confidence interval [CI] 1.08-3.94, P=0.029; OR 2.00, 95% CI 1.10-3.71, P=0.025, OR 1.86, 95% CI 1.02-3.42, P=0.044, respectively).
In this study, the incidence of 3GC-R BSI among children was retrospectively evaluated. Patients with a history of carbapenem administration, an elevated pSOFA score ≥2 and who were administrated antimicrobial agents before blood culture had an increased risk of 3GC-R BSI.
耐第三代头孢菌素(3GC-R)血流感染(BSI)与预后不良相关。我们调查了儿童3GC-R ()BSI的发生率及危险因素。
回顾性纳入重庆医科大学附属儿童医院住院的BSI患者。采用单因素和多因素logistic回归分析确定3GC-R BSI的独立危险因素。
纳入252例BSI患儿。死亡率为11.51%(29/252)。3GC-R 感染率为48.81%(123/252),住院期间BSI发病率为每1000人日18.58例。约一半(47.22%,119/252)的儿童感染了 产生的超广谱β-内酰胺酶(ESBLs)。超过三分之一(37.30%,94/252)的儿童接受了不必要的碳青霉烯类药物治疗。根据我们的logistic回归分析,碳青霉烯类药物使用史、小儿序贯器官衰竭评估(pSOFA)评分≥2升高以及血培养前使用抗菌药物与3GC-R BSI独立相关(比值比[OR]分别为2.05,95%置信区间[CI]1.08-3.94,P=0.029;OR 2.00,95%CI 1.10-3.71,P=0.025,OR 1.86,95%CI 1.02-3.42,P=0.044)。
本研究回顾性评估了儿童3GC-R BSI的发生率。有碳青霉烯类药物使用史、pSOFA评分≥2升高且在血培养前使用抗菌药物的患者发生3GC-R BSI的风险增加。